AIP
FULC icon

Ameritas Investment Partners’s Fulcrum Therapeutics FULC Stock Holding History

Ameritas Investment Partners’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Hold
4,898
– – ﹤0.01% 2813
2026
Q1 		$37.6K Buy
4,898
+1,300
+36% +$12.1K ﹤0.01% 2271
2025
Q4 		$40.7K Hold
3,598
– – ﹤0.01% 2264
2025
Q3 		$33.1K Sell
3,598
-2,481
-41% -$18K ﹤0.01% 2433
2025
Q2 		$41.8K Hold
6,079
– – ﹤0.01% 2302
2025
Q1 		$17.5K Hold
6,079
– – ﹤0.01% 2611
2024
Q4 		$28.6K Hold
6,079
– – ﹤0.01% 2481
2024
Q3 		$21.7K Hold
6,079
– – ﹤0.01% 2611
2024
Q2 		$37.7K Buy
+6,079
New +$46K ﹤0.01% 2298
2023
Q2 		– Sell
-3,342
Closed -$9.53K – 3147
2023
Q1 		$9.53K Hold
3,342
– – ﹤0.01% 2739
2022
Q4 		$42.2K Buy
3,342
+1,300
+64% +$8.48K ﹤0.01% 2179
2022
Q3 		$16K Hold
2,042
– – ﹤0.01% 2622
2022
Q2 		$10K Hold
2,042
– – ﹤0.01% 2829
2022
Q1 		$48K Hold
2,042
– – ﹤0.01% 2079
2021
Q4 		$36K Hold
2,042
– – ﹤0.01% 2331
2021
Q3 		$58K Buy
2,042
+942
+86% +$17.8K ﹤0.01% 2057
2021
Q2 		$12K Hold
1,100
– – ﹤0.01% 2900
2021
Q1 		$13K Hold
1,100
– – ﹤0.01% 2741
2020
Q4 		$13K Hold
1,100
– – ﹤0.01% 2678
2020
Q3 		$9K Hold
1,100
– – ﹤0.01% 2763
2020
Q2 		$20K Hold
1,100
– – ﹤0.01% 2341
2020
Q1 		$13K Buy
1,100
+720
+189% +$11.5K ﹤0.01% 2393
2019
Q4 		$6K Hold
380
– – ﹤0.01% 2873
2019
Q3 		$3K Buy
+380
New +$4.2K ﹤0.01% 2982

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameritas Investment Partners's FULC Position: Q2 2026 in Review

Ameritas Investment Partners held its Fulcrum Therapeutics (FULC) position steady in Q2 2026 at 4,898 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

Ameritas Investment Partners first reported a position in FULC in Q3 2019 and has held it in 24 quarters since. The position peaked at $58K in Q3 2021. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Ameritas Investment Partners held 4,898 shares of Fulcrum Therapeutics worth $17.9K as of Q2 2026.
  • Ameritas Investment Partners left its Fulcrum Therapeutics share count unchanged in Q2 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2813 holding.
  • Ameritas Investment Partners first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 24 quarters since.
  • Ameritas Investment Partners's Fulcrum Therapeutics position peaked at $58K in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.